Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yolande Lievens

Showing results (51-60 of 182) with videos related to

Pageof 19
Sort By:
International Journal of Radiation Oncology, Biology, Physics|September 8, 2018
Automated Instead of Manual Treatment Planning? A Plan Comparison Based on Dose-Volume Statistics and Clinical PreferenceBarbara Vanderstraeten, Bruno Goddeeris, Katrien Vandecasteele, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 29, 2016
How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysisJosep M Borras, Yolande Lievens, Michael Barton, et al.
Acta Oncologica (Stockholm, Sweden)|August 25, 2017
Adaptive radiotherapy for locally advanced non-small cell lung cancer: dosimetric gain and treatment outcome predictionPatrick Berkovic, Leen Paelinck, Akos Gulyban, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2019
Radiation Oncology. Optimal Health for All, Together. ESTRO vision, 2030Yolande Lievens, Umberto Ricardi, Philip Poortmans, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 8, 2023
A systematic literature review of definitions and classification systems for radiotherapy innovation: A first step towards building a value-based assessment tool for radiation oncologyMiet Vandemaele, Marianne Aznar, Pierre Blanchard, et al.
The Lancet. Oncology|March 5, 2026
An international modified Delphi study to prioritise levels of evidence and outcomes to appraise radiotherapy innovation in the ESTRO Value-Based Radiation Oncology frameworkMiet Vandemaele, Michelle Leech, Marianne Aznar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 10, 2021
Variable and fixed costs in NHS radiotherapy; consequences for increasing hypo fractionationKatie Spencer, Noemie Defourny, David Tunstall, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2022
Completeness of Reporting Oligometastatic Disease Characteristics in the Literature and Influence on Oligometastatic Disease Classification Using the ESTRO/EORTC NomenclatureDaan Nevens, Aurélien Jongen, Isabelle Kindts, et al.
European Journal of Cancer (Oxford, England : 1990)|October 9, 2023
Gender inequity in cancer research leadership in Europe: Time to actMark Lawler, Grant Lewison, Kathy Oliver, et al.
BMC Cancer|September 6, 2019
A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET)Carole Mercier, Piet Dirix, Piet Ost, et al.
Pageof 19

Showing results (51-60 of 182) with videos related to

Sort By:
Pageof 19
International Journal of Radiation Oncology, Biology, Physics|September 8, 2018
Automated Instead of Manual Treatment Planning? A Plan Comparison Based on Dose-Volume Statistics and Clinical PreferenceBarbara Vanderstraeten, Bruno Goddeeris, Katrien Vandecasteele, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 29, 2016
How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysisJosep M Borras, Yolande Lievens, Michael Barton, et al.
Acta Oncologica (Stockholm, Sweden)|August 25, 2017
Adaptive radiotherapy for locally advanced non-small cell lung cancer: dosimetric gain and treatment outcome predictionPatrick Berkovic, Leen Paelinck, Akos Gulyban, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2019
Radiation Oncology. Optimal Health for All, Together. ESTRO vision, 2030Yolande Lievens, Umberto Ricardi, Philip Poortmans, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 8, 2023
A systematic literature review of definitions and classification systems for radiotherapy innovation: A first step towards building a value-based assessment tool for radiation oncologyMiet Vandemaele, Marianne Aznar, Pierre Blanchard, et al.
The Lancet. Oncology|March 5, 2026
An international modified Delphi study to prioritise levels of evidence and outcomes to appraise radiotherapy innovation in the ESTRO Value-Based Radiation Oncology frameworkMiet Vandemaele, Michelle Leech, Marianne Aznar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 10, 2021
Variable and fixed costs in NHS radiotherapy; consequences for increasing hypo fractionationKatie Spencer, Noemie Defourny, David Tunstall, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2022
Completeness of Reporting Oligometastatic Disease Characteristics in the Literature and Influence on Oligometastatic Disease Classification Using the ESTRO/EORTC NomenclatureDaan Nevens, Aurélien Jongen, Isabelle Kindts, et al.
European Journal of Cancer (Oxford, England : 1990)|October 9, 2023
Gender inequity in cancer research leadership in Europe: Time to actMark Lawler, Grant Lewison, Kathy Oliver, et al.
BMC Cancer|September 6, 2019
A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET)Carole Mercier, Piet Dirix, Piet Ost, et al.
Pageof 19